These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17589291)

  • 21. Differences in the requirement of antigen-presenting cells for long-term growth among cytomegalovirus-specific Th clonotypes.
    Santamaria P; Lewis C; Barbosa JJ
    Eur J Immunol; 1993 Nov; 23(11):2972-9. PubMed ID: 8223874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strong and sustained effector function of memory- versus naïve-derived T cells upon T-cell receptor RNA transfer: implications for cellular therapy.
    Thomas S; Klobuch S; Besold K; Plachter B; Dörrie J; Schaft N; Theobald M; Herr W
    Eur J Immunol; 2012 Dec; 42(12):3442-53. PubMed ID: 22930221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
    Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY
    Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.
    Jenkins MK; Taylor PS; Norton SD; Urdahl KB
    J Immunol; 1991 Oct; 147(8):2461-6. PubMed ID: 1717561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cells.
    Yamahira A; Narita M; Nakamura T; Watanabe N; Kaji M; Taniguchi T; Hashimoto S; Furukawa T; Toba K; Aizawa Y; Kuzushima K; Takahashi M
    Leuk Res; 2011 Jun; 35(6):793-9. PubMed ID: 21216464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
    Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
    Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of antigen-specific CD8+ cytolytic T cells by the exogenous bacterial antigen streptolysin O in rhesus monkeys.
    Chizzolini C; Millet PG; Olsen-Rasmussen MA; Collins WE
    Eur J Immunol; 1991 Nov; 21(11):2727-33. PubMed ID: 1682153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells cross-talk with tumour antigen-specific CD8
    Eiraku Y; Terunuma H; Yagi M; Deng X; Nicol AJ; Nieda M
    Clin Exp Immunol; 2018 Oct; 194(1):54-66. PubMed ID: 30009488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two roles for Ia in antigen-specific T lymphocyte activation.
    Kim KH; Shivdasani RA; Thomas DW
    J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.
    Pérez-Díez A; Butterfield LH; Li L; Chakraborty NG; Economou JS; Mukherji B
    Cancer Res; 1998 Dec; 58(23):5305-9. PubMed ID: 9850054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective binding of CD4 and CD8 T-cells to antigen presenting cells for enrichment of CMV and HIV specific T-lymphocytes.
    Li Pira G; Ivaldi F; Manca F
    J Immunol Methods; 2012 Feb; 376(1-2):125-31. PubMed ID: 22251662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinoma.
    Gückel B; Meyer GC; Rudy W; Batrla R; Meuer SC; Bastert G; Wallwiener D; Moebius U
    Cancer Gene Ther; 1999; 6(3):228-37. PubMed ID: 10359208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
    Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
    Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
    Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.